Ranbaxy gets nod to manufacture & mkt ARV drugs for children in India
Thursday, December 06, 2007 18:00 IST Our Bureau, Mumbai
Ranbaxy Laboratories Ltd has received approval to manufacture and market Coviro-LS kid and Coviro-LS kid DS, both double anti-retroviral (ARV) and fixed dose combination, dispersible tablets for children, in India.